Kiora Pharmaceuticals, Inc. (KPRX) Financials

KPRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 23.8 million 6.9 million
March 31, 2026 21.2 million 7.3 million
Dec. 31, 2025 24.3 million 8.1 million
Sept. 30, 2025 29.9 million 7.5 million

KPRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -1.9 million 109310
March 31, 2026 -3.2 million 209510
Dec. 31, 2025 -2.3 million 234448
Sept. 30, 2025 -1.3 million 254398

KPRX Net Income

No data available :(

KPRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 16.8 million - 160597
March 31, 2026 13.9 million - 195369
Dec. 31, 2025 17.1 million - 203798
Sept. 30, 2025 19.4 million - 404165

KPRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 6.2 million
March 31, 2026 4.2 million
Dec. 31, 2025 4.1 million
Sept. 30, 2025 4.4 million

KPRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 23456 2.1 million 1.4 million -
March 31, 2026 5018 2.1 million 1.6 million -
Dec. 31, 2025 78163 1.2 million 1.5 million -
Sept. 30, 2025 432 1.1 million 1.4 million -

KPRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 41979
Dec. 31, 2025 - 10508
Sept. 30, 2025 - 38235

KPRX

Price: $2.59

52 week price:
1.77
3.01

Earnings Per Share: -2.46 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 47600

Market Capitalization: 11.7 million

Links: